Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Paredes

Showing results (91-100 of 309) with videos related to

Pageof 31
Sort By:
AIDS Research and Human Retroviruses|January 20, 2016
Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical TrialJosé R Santos, Josep M Llibre, Isabel Bravo, et al.
Journal of the International AIDS Society|November 14, 2014
Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTCJosé Ramón Santos, María Saumoy, Adrian Curran, et al.
Journal of the International AIDS Society|November 15, 2014
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failureAnna Schultze, Roger Paredes, Caroline Sabin, et al.
The Journal of Antimicrobial Chemotherapy|April 3, 2018
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trialJose L Blanco, Jhon Rojas, Roger Paredes, et al.
Plos One|January 28, 2017
Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or DeathMaria Casadellà, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic ReviewSergio Marin, Alba Martin Val, Maite Bosch Peligero, et al.
Retrovirology|August 4, 2016
Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ARTMaria C Puertas, Marc Noguera-Julian, Marta Massanella, et al.
Plos One|November 24, 2011
Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-scoreAlessandro Cozzi-Lepri, Mattia C F Prosperi, Jesper Kjær, et al.
Haematologica|May 13, 2022
The gut microbiome in patients with chronic lymphocytic leukemiaTereza Faitová, Rebecka Svanberg, Caspar Da Cunha-Bang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2002
Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimensCarmina R Fumaz, Albert Tuldrà, Ma José Ferrer, et al.
Pageof 31

Showing results (91-100 of 309) with videos related to

Sort By:
Pageof 31
AIDS Research and Human Retroviruses|January 20, 2016
Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical TrialJosé R Santos, Josep M Llibre, Isabel Bravo, et al.
Journal of the International AIDS Society|November 14, 2014
Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTCJosé Ramón Santos, María Saumoy, Adrian Curran, et al.
Journal of the International AIDS Society|November 15, 2014
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failureAnna Schultze, Roger Paredes, Caroline Sabin, et al.
The Journal of Antimicrobial Chemotherapy|April 3, 2018
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trialJose L Blanco, Jhon Rojas, Roger Paredes, et al.
Plos One|January 28, 2017
Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or DeathMaria Casadellà, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic ReviewSergio Marin, Alba Martin Val, Maite Bosch Peligero, et al.
Retrovirology|August 4, 2016
Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ARTMaria C Puertas, Marc Noguera-Julian, Marta Massanella, et al.
Plos One|November 24, 2011
Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-scoreAlessandro Cozzi-Lepri, Mattia C F Prosperi, Jesper Kjær, et al.
Haematologica|May 13, 2022
The gut microbiome in patients with chronic lymphocytic leukemiaTereza Faitová, Rebecka Svanberg, Caspar Da Cunha-Bang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2002
Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimensCarmina R Fumaz, Albert Tuldrà, Ma José Ferrer, et al.
Pageof 31